Acasti Pharma
ACST
$2.78
Share price
3.73%
Change (1 day)
504.35%
Change (1 year)
Categories
Acasti Pharma (ACST) - P/B ratio
P/B ratio as of May 2024 : 0.4040
According to Acasti Pharma
's latest financial reports the company has a price-to-book ratio of 0.4040.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Acasti Pharma - P/B ratio (from 2020 to 2019)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.4200 | 81.74% |
| 2022-12-31 | 0.2311 | -54.39% |
| 2021-12-31 | 0.5067 | -59.17% |
| 2020-12-31 | 1.24 | -102.09% |
| 2019-12-31 | -59.5 | -1601.87% |
| 2018-12-31 | 3.96 | 60.93% |
| 2017-12-31 | 2.46 | 93.91% |
| 2016-12-31 | 1.27 | -23.12% |
| 2015-12-31 | 1.65 | -16.15% |
| 2014-12-31 | 1.97 | -66.73% |
| 2013-12-31 | 5.92 | -59.6% |
| 2012-12-31 | 14.6 | 122.18% |
| 2011-12-31 | 6.59 | |
| 2010-12-31 | N/A | |
| 2009-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Omeros Corporation OMER | -13.1 | -3,338.17% | 🇺🇸 USA |